enGene Therapeutics (ENGN) Total Liabilities (2022 - 2026)
enGene Therapeutics' Total Liabilities was $58.03 million in fiscal Q3 2026 (quarter ended Jul 31, 2026), up 29.3% from $44.88 million a year earlier and up 10.8% from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Total Liabilities (2022 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), Total Liabilities at enGene Therapeutics came in at $53.76 million, up 39.4% from FY2024.
- Total Liabilities shows a three-year compound annual growth rate of -18.8% (FY2022 to FY2025).
- In earlier fiscal years, Total Liabilities was $38.56 million in FY2024 (+166.4%), $14.47 million in FY2023 (-85.6%) and $100.52 million in FY2022.
- The fiscal Q3 2026 figure marks the highest quarterly Total Liabilities since fiscal Q4 2022.
- Compared with a year earlier, Total Liabilities has increased for eight straight quarters, with growth averaging 48.8% over the last eight quarters.
- The best year-over-year quarter for Total Liabilities over five years was fiscal Q4 2024 (growth of 166.4%); the worst was fiscal Q4 2023 (a decline of 85.6%).
- Per Business Quant data, ENGN's Total Liabilities in the three fiscal quarters before Q3 2026 was $52.36 million (Q2 2026), $55.57 million (Q1 2026) and $53.76 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 108.40 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 115.90 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 141.05 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 87.82 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 80.09 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 65.46 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 83.95 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 37.53 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 115.64 Bn |
| 10 | enGene Therapeutics | 105.88 Mn | -888.59 Mn | - | 58.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 58.03 Mn |
| Apr 30, 2026 | 52.36 Mn |
| Jan 31, 2026 | 55.57 Mn |
| Oct 31, 2025 | 53.76 Mn |
| Jul 31, 2025 | 44.88 Mn |
| Apr 30, 2025 | 39.36 Mn |
| Jan 31, 2025 | 35.98 Mn |
| Oct 31, 2024 | 38.56 Mn |
| Jul 31, 2024 | 36.55 Mn |
| Apr 30, 2024 | 30.56 Mn |
| Jan 31, 2024 | 31.04 Mn |
| Oct 31, 2023 | 14.47 Mn |
| Oct 31, 2022 | 100.52 Mn |
API Access
enGene Therapeutics Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();